Your browser of choice has not been tested for use with If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More

Biotechnology Stocks

A list of publicly traded biotechnology and biotech-related stocks.
Sun, Jan 17th, 2021

Biotechnology (biotech) stocks are publicly traded companies that develop pharmaceutical drugs used in the treatment of disease. Many of these companies are exploring treatment for the COVID-19 virus. You can use Barchart's Biotech Stocks list to find investment opportunities and compare stocks involved in this hot industry.

View Profiles of these companies.

Biotechnology Stocks News

INVO Bioscience Expands Distribution of INVOcell Into the Pakistan Infertility Market with Galaxy Pharma Ltd.

SARASOTA, Fla. , Jan. 15, 2021 /PRNewswire/ --  INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System...

INVO : 3.04 (-0.65%)
Lantern Pharma Announces Pricing of $60 Million Public Offering

DALLAS , Jan. 14, 2021 /PRNewswire/ -- Lantern Pharma (Nasdaq: LTRN), a clinical-stage biopharma company using its proprietary RADR ® artificial intelligence ("A.I.") platform to transform...

LTRN : 14.34 (-1.17%)
Ascentage Pharma Presents Updates on its Global Clinical Development at the J.P. Morgan 39th Annual Healthcare Conference

Turkey approves China-based Sinovac vaccine's emergency use

ANKARA, Turkey (AP) — Turkish authorities gave the go-ahead for the emergency use of the COVID-19 vaccine produced by China’s Sinovac Biotech Ltd. on Wednesday, paving the way for the rollout for Turkey’s...

SVA : 6.47 (-0.31%)
ESSA Pharma Announces Clinical Collaboration with Janssen to Evaluate EPI-7386 Combination for Patients with Metastatic Castration-Resistant Prostate Cancer

HOUSTON and VANCOUVER, BC , Jan. 13, 2021 /PRNewswire/ - ESSA Pharma Inc. (Nasdaq: EPIX) ("ESSA" or the "Company"), a clinical-stage pharmaceutical company focused on developing novel therapies...

EPIX : 16.01 (+1.14%)
EPI.VN : 8.200 (+7.19%)
Actinium and Astellas Announce Research Collaboration Focused on Novel Actinium-225 Based Targeted Radiotherapies

NEW YORK , Jan. 13, 2021 /PRNewswire/ --  Actinium Pharmaceuticals, Inc.  (NYSE AMERICAN: ATNM) ("Actinium") today announced the research collaboration with Astellas Pharma Inc. (TSE:4503)...

ATNM : 8.30 (-1.78%)
ALPMY : 15.8800 (-0.19%)
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar